COLL
COLL
NASDAQ · Pharmaceuticals

Collegium Pharmaceutical Inc

$33.25
+0.02 (+0.06%)
As of Mar 25, 10:01 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 10 83%
Hold 2 17%
Sell 0 0%
Price Target
Analyst Price Target +44.8% upside
Low Target $33.48
Average Target $48.15
High Target $61.72
Current Price $33.25
Current
$33.25
Target
$48.15
$33.48 $48.15 avg $61.72
Scenario Analysis
Bear Case
$33.48
0.7%
Low target
Base Case
$48.15
+44.8%
Avg target
Bull Case
$61.72
+85.6%
High target
Risk/Reward
123.8x
Highly favorable
Price in Context
52-Week High
$50.79
-34.5% from high
52-Week Low
$23.23
+43.1% from low
Target vs 52W High
$48.15
-5.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%